To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
News|Articles|February 22, 2024
- Drug Topics January/February 2024
- Volume 168
- Issue 01
OTC Product Roundup: Cough, Cold, and Flu
Author(s)Lauren Biscaldi, MS
These OTC products are recommended to address a variety of symptoms that occur during cold and flu seasons.
Advertisement
READ MORE:
Articles in this issue
over 2 years ago
Lecanemab-irmb Approved for Alzheimer Diseaseover 2 years ago
Stealing With Our Eyes Openover 2 years ago
2024 Pharmacy Forecast: A Focus on Mental Healthalmost 3 years ago
HHS Issues Reminder to Health Plans: Provide Contraceptive Coveragealmost 3 years ago
Paxlovid Found Not to Reduce Long COVID RiskAdvertisement
Related to this article
Lara Zakaria, PharmD, MS, CNS, FMCP, illustrates the breadth of health technology going in and out of community pharmacy practice.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Lara Zakaria, PharmD, MS, CNS, FMCP, discusses her perspectives regarding the emergence of wearable technology among community pharmacy patients.
Alyssa Eisenberg, PharmD, discusses key industry challenges and developments as community pharmacists continue to impact patient outcomes across the US.
Allison Schneider, MPH, provides expertise on how IRA drug price negotiations have impacted pharmacies in 2026 and what’s to come in the years ahead.
Shantel Upshaw Houston shares tips to prevent burnout, explains how pharmacists fill gaps in care, and urges midcareer peers to mentor students.
Advertisement
Advertisement
Trending on Drug Topics
1
CagriSema Reduces Weight in Women Across Menopause Stages, HT Use
2
Future IRA Drug Negotiations Expected to Compound Pharmacy Burden
3
EloraTZP Shows Greater Weight Loss, A1C Reduction Than Tirzepatide
4
Pharmacist Roles, Risks in Guiding AI-Enabled Medical Device Use
5